Standard Therapy or Individualized Immunosuppression For Lowering Adverse Event Risk

Inclusion Criteria: * Adult transplant recipients ≥18 years of age who have a functional allograft and have undergone kidney transplantation between six months and two years prior to study enrollment * Receiving mycophenolate mofetil for maintenance transplant immunosuppression at the time of the screening visit Exclusion Criteria: * Evidence of rejection on routine six month post-transplant biopsy * Prior intolerance to mycophenolate mofetil necessitating drug discontinuation * Are or are planning to become pregnant, due to inability to take mycophenolate * Are marginally housed, due to concerns regarding routine follow-up * Are actively participating in a different interventional trial that may affect immunosuppression dosing * Are unwilling to consent to participate * Institutionalized individuals or prisoners * Are actively abusing illicit drugs or alcohol * Have a history of poor or doubtful compliance (e.g., frequently missed appointments) * Have cognitive impairment prohibiting participation in the study